Expanded to include considerations for treatment and prophylaxis of Monkeypox virus infection in people with immunocompromising Frank I, et al. This drug continues to be evaluated for effectiveness and toxicity. The ACIP unanimously voted in favor of the JYNNEOS booster vaccine after the 2-dose JYNNEOS primary series. For patients who are not eligible for STOMP or who decline to participate, tecovirimat can be provided under an expanded access protocol. Is there a difference in the dosing interval between the standard regimen (subcutaneous administration) and the alternative regimen (intradermal administration) of JYNNEOS vaccine? A take is postvaccination lesion often used as a marker of successful vaccination after ACAM2000. Fields virology: DNA viruses, vol 2. Mpox (monkeypox) is a viral disease that occurs mostly in central and western Africa. Denise Jamieson is a university employee, and this article represents her own work. Young children, children with eczema and other skin conditions, and children with immunocompromising conditions may be at increased risk of severe disease. In total, human monkeypox has now Jezek Z, Grab B, Szczeniowski M, Paluku KM, Mutombo M. Clinico-epidemiological features of monkeypox patients with an animal or human source of infection. The effectiveness of antiviral medications as mpox PEP is unknown. **** Examples include eczema, burns, impetigo, varicella-zoster, herpes, severe acne, severe diaper dermatitis with extensive areas of denuded skin, psoriasis, or Darier disease (keratosis follicularis). Instruct patients with suspected mpox infection to isolate themselves and avoid close contact with other people and animals, including pets. Previous smallpox vaccination probably provides some protection, but it may not be lifelong. Human monkeypox infection: A family cluster in the midwestern United States. Vaccination should also be offered to people with the highest potential for exposure to mpox. This is because it has not been possible to obtain complete information about Imvanex due to the rarity of the diseases. In addition, because of the similarity between the virus in Imvanex (modified vaccinia virus Ankara) and the variola (smallpox), monkeypox and vaccinia viruses, antibodies produced against it are expected to protect against monkeypox, smallpox as well as the disease caused by vaccinia. Intradermal vaccination is a method that injects the vaccine under a more shallow layer of skin, typically on the inner side of the forearm. Once test results are known, it is important to correctly interpret results and perform clinical management in collaboration with the jurisdictional health department. Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. Brincidofovir and cidofovir should not be used simultaneously. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page. Adult men under 50 who were eligible for a vaccine but didn't get one were 14 times more likely to get the disease than people who did get the first vaccine dose, according to the findings. How soon after vaccination is someone expected to be protected from mpox? The illness typically lasts 2-4 weeks. United Kingdom Health Services Agency (UK HSA). Isolate (at home or in a healthcare facility, as clinically indicated). Halsell JS, Riddle JR, Atwood JE, et al. However, co-infections with mpox and STIs have been reported and the presence of an STI does not rule out mpox. CDC twenty four seven. For information, please see Vaccine Administration Errors and Deviations. For laboratory personnel and designated response team members, ACIP recommends use of JYNNEOS for primary vaccination as an alternative to ACAM2000. Therefore, effective vaccination can be assumed for immunocompetent persons. or redistributed. Patients should be informed about the clinical trial for tecovirimat (, and encouraged to consider enrollment. The research reviewed monkeypox case and vaccine uptake data from July 4 through November 3, 2022, to estimate the vaccines effectiveness among the gay, bisexual and men who have sex with men cohort that was eligible for vaccination in the UK. Petersen BW, Harms TJ, Reynolds MG, Harrison LH. Can people who are pregnant or breastfeeding be vaccinated? Caregivers or family members who do not have suspected or confirmed mpox can provide routine care to an uninfected neonate who is born to a person with mpox. Outcomes after an infection in a vaccinated person could be particularly severe in these populations, particularly following exposure to more virulent orthopoxviruses (3); for this reason, vaccine recipients might consider avoiding high-risk exposures until after temporary conditions (e.g., pregnancy or transient therapy with immunocompromising therapeutics) are completed. Inform the recipient of the potential for local and systemic adverse events. Copy a link to the article entitled UK study suggests single dose of monkeypox vaccine is 78% effective, Seven science and tech breakthroughs you may have missed this year, How to use the brains own immune cells to stave off Alzheimers, Harvard and Kraft Heinz are trying to make sugar healthier, Just a few short bursts of physical activity each day might yield huge health benefits, New future-proof drug can fight COVID-19 and the common cold, $3.5 million treatment for hemophilia wins FDA approval. MONKEYPOX VACCINE, TESTING, and TREATMENT INFORMATION We have Bavarian Nordic Monkeypox JYNNEOS vaccine. The behavior of vaccinated individuals who may have been more likely to take other precautions as well, like reducing the number of sexual partners may artificially inflate the apparent effect of the vaccine. What are the implications for public health practice? Decisions regarding discontinuation of isolation precautions at a healthcare facility should be made in consultation with the local or state health department. Vaccination is not expected to provide benefit if it is given after onset of signs or symptoms of mpox, after a diagnosis of mpox, or after recovery from mpox disease. JYNNEOS is not licensed for persons aged <18 years and has not been rigorously evaluated in this population. It is not yet known how long the protection will last. My patient's orthopox or mpox test result is pending. URL addresses listed in MMWR were current as of When a patient is isolating in their home, what should they do? In this event, health officials would not be rationing vaccines or using only the newer-generation vaccine, according to Adalja. The US hastwo vaccines in its national stockpile that work against monkeypox. CDC is not responsible for the content Should patients be concerned about their pets? They help us to know which pages are the most and least popular and see how visitors move around the site. 1988;66(4):459-64. However, they have been shown to be effective against orthopoxviruses in in vitro and animal studies. The only vaccine that is authorized and recommended for use in children or adolescents for PEP is the JYNNEOS vaccine. In the European Union, this vaccine has been approved for prevention of smallpox. Over 11% of 83 children and adolescents were hospitalized with no patients requiring intensive care; 22% were treated with tecovirimat; all patients recovered without sequalae. When indicated based on clinical presentation, evaluation for etiologies other than mpox should be done at the time of testing for mpox, particularly when no epidemiologic link to a person with mpox has been identified. Immune globulin may also be considered for infants under 6 months of age, given their immature immune systems and possible decreased responses to vaccination. JAMA 2022;327:33140. We conducted a systematic review to assess how monkeypox epidemiology has evolved since it was first diagnosed in 1970 in the Democratic Republic of the Congo. See, Patients who have been exposed to mpox, even if they do not have symptoms, may be eligible for post-exposure vaccination. Safe sex, barrier practices (i.e., wearing condoms) are recommended, but there is little data to support the length of time patients need to wear condoms. The remaining cases were unvaccinated. Clinicians with mpox patients necessitating brincidofovir treatment need to submit an e-IND request to FDA by email (DDI.EIND@fda.hhs.gov) or phone 301-796-3400 or 1-855-543-3784 during normal business hours (8 am-4:30 pm ET M-F). The vaccinia virus in Imvanex cannot replicate in human cells and hence is less likely to cause side effects than conventional smallpox vaccines. Do I need to observe patients after they receive JYNNEOS vaccination? Potential vaccinees should weigh the risks and benefits of each vaccine when deciding which to receive. Bavarian Nordic, Data on file (clinical study report MEA-HFN-002). Providers administering JYNNEOS under the Emergency Use Authorization (EUA) are required to report vaccine administration errors, whether or not associated with an adverse event to the Vaccine Adverse Event Reporting System (VAERS). JYNNEOS involves a replication-deficient virus and has fewer contraindications, no risk for inadvertent inoculation and autoinoculation, and is associated with fewer serious adverse events compared with ACAM2000 (Table 2). For health care personnel who administer ACAM2000 or care for patients infected with orthopoxviruses, ACIP recommends use of JYNNEOS (as an alternative to ACAM2000), based on shared clinical decision-making. Because of this, it's possible people born before the early 1970s who got the smallpox vaccine might have somecross-protective immunityagainst monkeypox, according to the WHO, but there is "little immunity" to younger people living in non-endemic countries because they've had no exposure to a similar virus. This material may not be published, broadcast, rewritten, J Infect Dis. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance. Inadvertent intramuscular (IM) administration of the standard dose (0.5 mL) of JYNNEOS is a vaccine administration error but does not need to be repeated and the dose can be counted as valid. In most cases no. Oral tecovirimat dosing is most practical for children who weigh at least 13 kilograms (approximately 28 pounds), can take capsules or the contents of a capsule mixed with soft food, and are able to eat a fatty meal to ensure optimal drug absorption. Safety and Immunogenicity of Modified Vaccinia Anakara-Bavarian Nordic Smallpox Vaccine in Vaccinia-Nave and Experienced Human Immunodeficiency Virus-Infected Individuals: An What strains have been identified in this outbreak? Adler H, Gould S, Hine P, et al. Available from the US Strategic National Stockpile (SNS). Jynneos, a newer-generation monkeypox and smallpox vaccine, is not the same type of vaccine as the one used to eradicate smallpox and doesn't leave a scar. Poxviruses. Brincidofovir is made available from the Strategic National Stockpile for treatment of mpox to clinicians who request and obtain an FDA-authorized single-patient emergency use IND (e-IND). N Engl J Med 2019;381:1897908. Every year, the Agency will review any new information that becomes available and this overview will be updated as necessary. The CDC provides general guidance on cleaning and disinfecting non-healthcare settings (e.g., homes, cars) where an individual with mpox spent significant time. The use of the antiviral medications brincidofovir [ 670KB, 21 Pages]and cidofovir[ 828KB, 6 Pages]may also be considered, but these should be used with caution due to potential toxicity. That vaccine and ACAM2000 contain a replicating Vaccinia virus and are associated with adverse events caused by uncontrolled viral replication, such as progressive vaccinia and eczema vaccinatum. People can be vaccinated after known or suspected exposure to someone with mpox. You will be subject to the destination website's privacy policy when you follow the link. Continued risk refers to persistent risk due to occupational work performed. A separate clean administration station for each vaccine type should be set up to prevent medication errors. J Infect Dis 1970;122:3039. No. MMWR Morb Mortal Wkly Rep. 2022;71(22):734-742. Risks associated with vaccinia virus in the laboratory. Both vaccines performed well in the earlier phases of development. U.S. Army Staff Sergeant Bobby Schelske and attorney Wendy Cox joined 'Fox & Friends Weekend' to discuss a Texas judge putting a temporary pause on soldier discharges over the vaccine mandate. New analysis by the UK Health Security Agency (UKHSA) suggests that one dose of Bavarian Nordics monkeypox vaccine is 78% effective at preventing infection. Persons with immunocompromising conditions. Immunocompromised persons, including those receiving immunosuppressive therapy, may have a diminished immune response to JYNNEOS because of their immunocompromised status. Additional precautions such as steam cleaning can be considered if there is concern about contamination. 1Division of High Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, CDC; 2Epidemic Intelligence Service, CDC; 3Connecticut State Public Health Laboratory, Rocky Hill, Connecticut; 4Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; 5Biomedical Advanced Research and Development Authority, U.S. Department of Health and Human Services, Washington, DC; 6University of Arizona College of Medicine, Phoenix, Arizona; 7Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada; 8Nationwide Childrens Hospital, The Ohio State University College of Medicine, Columbus, Ohio; 9University of Washington, Seattle, Washington. Safety and Immunogenicity of Modified Vaccinia Ankara-Bavarian Nordic Smallpox Vaccine in Vaccinia-Naive and Experienced Human Immunodeficiency Virus-Infected Individuals: An What medications can be given to treat mpox? However, JYNNEOS vaccine is replication-deficient and therefore should not present a risk of transmission to breastfed infants. Imvanex has been authorised under exceptional circumstances. ; Vaccinia Case Definition Development Working Group; Advisory Committee on Immunization Practices-Armed Forces Epidemiological Board Smallpox Vaccine Safety Working Group. Disinfecting Home and Other Non-Healthcare Settings. What should prompt clinical suspicion for mpox infection? Caution should be used when considering the administration of ACAM2000 or JYNNEOS to children and adolescents aged <18 years. For information about skin care for individuals with mpox lesions, please see Monkeypox: Caring for the Skin. 2017 Oct 17;216(7):795-797. Hand hygiene should be performed immediately following removal of gloves. The patient may experience increased local reaction at the vaccine site due to the inadvertent IM administration. The European Medicines Agency considered that Imvanex is effective at triggering the production of antibodies against smallpox to a level that provides protection at least as high as that from conventional smallpox vaccines. Predrawn vaccine must be labeled with vaccine name, lot number, date and time prepared, and preparers initials, and MUST BE refrigerated. 22/12/2022 Imvanex - EMEA/H/C/002596 - N/0086. Pregnant women. However, because the mechanism for myopericarditis following receipt of ACAM2000 is thought to be an immune-mediated phenomenon, it is not known whether the antigen or antigens that precipitate autoantibodies are present in JYNNEOS as well. Vaccination, immune globulin, and antiviral medication can be used as mpox PEP. Based on the results from the GRADE methodology and findings within the EtR framework, ACIP unanimously voted in favor of recommending JYNNEOS boosters as an alternative to ACAM2000 boosters in persons who received ACAM2000 as the primary vaccine. Oster ME, Shay DK, Su JR, et al. For information on weight-based dosing of tecovirimat, see the EA-IND protocol [1 MB, 22 pages]. Regular booster doses are recommended for persons with ongoing occupational risk for exposure to orthopoxvirus infections. Recommendation of the Immunization Practices Advisory Committee (ACIP). If necessary, the US Department of Health and Human Services said it's alsoprepared to ship outthe ACAM2000 vaccine, which is in greater supply than Jynneos but remains a second choice in the monkeypox response because it has a side effect profile that isn't safe for certain people. Occurrences of serious adverse events are expected to be minimal because JYNNEOS is a replication-deficient virus vaccine. Centers for Disease Control and Prevention. To find a vaccine in San Francisco, here's the website. This vaccine is based on a strain of vaccinia virus (known generically as modified vaccinia Ankara Bavarian Nordic strain, or MVA-BN). An MSNBC contributor voiced disbelief after her children reportedly refused to have further vaccinations against COVID before the holidays. Early bathing is recommended for neonates born to individuals with suspected or confirmed mpox. Co-infections with mpox are possible. According to the CDC, you meet thecriteria for a monkeypox vaccine if: People who were exposed to someone with monkeypox may also get a vaccine. You can findproduct informationdocuments for centrally authorised human medicines on this website. How long immunity lasts after receiving of either vaccine is unknown. Bavarian Nordic. *** Public health authorities, at their own discretion, may approve a cohort of health care personnel, public health personnel, or both, to receive primary vaccination against orthopoxviruses for preparedness purposes (e.g., first responders who might participate in a smallpox or monkeypox outbreak). Hand hygiene (e.g., use of an alcohol-based hand rub or hand washing with soap and water) should be performed by infected persons and household contacts after touching lesion material, clothing, linens, or environmental surfaces that may have had contact with lesion material. The safety and efficacy of JYNNEOS has not been evaluated in breastfeeding women. What should be done if JYNNEOS vaccine is inadvertently given intramuscularly? All information these cookies collect is aggregated and therefore anonymous. A reportpublished on November 3rd, 2022 described the epidemiologic and clinical features of 83 cases of infection in children and adolescents. 2016 Jun;22(6):1014-21. A total of 82% of subjects seroconverted when given JYNNEOS booster, with very low (level 4) certainty in that estimate. Petersen BW, Damon IK, Pertowski CA, et al. YNNEOS is available for use as post exposure prophylaxis (PEP) for children and adolescents under 18 years determined to be at high risk for mpox infection under the Emergency Use Authorization (EUA)issued by the US Food and Drug Administration on August 9, 2022. https://www.fda.gov/media/75792/download. Components of U.S. Mpox Vaccination Strategy. For more information, see: Coadministration of JYNNEOS vaccine with the tuberculin skin test. Monkeypox is a viral disease that occurs mostly in central and western Africa. People who are pregnant: Available human data on JYNNEOS administered to people who are pregnant are insufficient to determine vaccine-associated risks in pregnancy. As for all medicines, data on the use of Imvanex are continuously monitored. Should they get the second dose? CDC will continue to monitor case data and available sciencefor new or changing information about transmission. Should someone who has had mpox as part of this outbreak be vaccinated? MMWR Morb Mortal Wkly Rep 2019;68:9436. This change is aligned with the recent World Health Organizationdecision. In laboratory tests, tecovirimat has been shown to stop the growth of the virus that causes smallpox and to be effective in treating animals that had diseases similar to smallpox (e.g., mpox). Smallpox vaccination and myopericarditis: a clinical review. All rights reserved. Smallpox was declared eliminated in the 1980s, and the last natural outbreak in the US happened in 1949. For more information, see Dosing Intervalsof JYNNEOS vaccine. People who are aware that a recent sex partner within the last 14 days was diagnosed with mpox. For detailed information on vaccines for mpox, see Considerations for Mpox Vaccination. These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. Jynneos, the monkeypox vaccine, hadn't been put to the real-world test until the current outbreak. This report describes the ACIP recommendations for the use of JYNNEOS for preexposure prophylaxis in persons at occupational risk for exposure to orthopoxviruses. When deciding whether to administer other vaccine(s) with ACAM2000 at the same time, the reactogenicity of ACAM2000 must be considered to balance the benefits and risks of multiple vaccine doses administered at the same time. Additionally, people with certain risk factors and recent experiences that might make them more likely to have been recently exposed to mpox; or put them at increased risk to be exposed in the future, can be considered for vaccination [i.e., expanded post-exposure prophylaxis (PEP++); or PrEP, respectively]. These cookies may also be used for advertising purposes by these third parties. The most common side effects with Imvanex (which may affect more than 1 in 10 people) are headache, nausea, myalgia (muscle pain), tiredness and injection site reactions (pain, redness, swelling, hardening and itching). Mutual Fund and ETF data provided by Refinitiv Lipper. A second vaccine is now available for persons for whom vaccination against orthopoxvirus infections is recommended. If the JYNNEOS vaccine and the TST are administered on the same day, the vaccine and the TST should be administered on different forearms, one on the left and one on the right. After considering geometric mean titer and seroconversion rate together, the Work Group estimated with very low (level 4) certainty that a small increase in disease prevention occurs after JYNNEOS booster versus the JYNNEOS primary series only. The Work Group estimated with very low (level 4) certainty that fewer serious adverse events occur after a JYNNEOS booster administered following completion of the JYNNEOS primary series compared with the JYNNEOS primary series (i.e., no booster dose). Because a correlate of protection has not been established and there is no known antibody titer level that will ensure protection, titer results should be interpreted with caution in such cases to avoid providing a false sense of security. New analysis by the UK Health Security Agency (UKHSA) suggests that one dose of Bavarian Nordics monkeypox vaccine is 78% effective at preventing infection. Thank you for taking the time to confirm your preferences. Because JYNNEOS is a replication-deficient vaccine, vaccination with JYNNEOS does not produce a take; however, clinical trials have demonstrated high rates of seroconversion after the 2-dose series. J Infect Dis. Identifying potential contacts will help them receive the proper treatments and protect others in the community from getting infected by mpox. There are very limited data for neonates and for young infants. Canadian Society of Allergy and Clinical Immunology. There can also be some pain and swelling around the injection site, which can result in what some are reporting as a temporary swollen lump around the injection site. At the beginning of the outbreak, Jynneos, the newer vaccine specifically approved to prevent monkeypox, was hard to come by for people who were eligible for the vaccine. In laboratory tests, cidofovir has also been shown to stop the growth of the virus that causes smallpox and to be effective in treating animals that had diseases similar to smallpox (e.g., mpox). Federal partners represented on the Work Group included FDA, the National Institutes of Health, the U.S. Department of Defense, and the U.S. Department of Health and Human Services-Biomedical Advanced Research and Development Authority. In: Howley PM, Knipe DM, Damania BA, Cohen JI, eds. These treatments should be reserved for unusual circumstances, such as very severe infections, disease progression or recrudescence (initial improvement followed by worsening) despite tecovirimat treatment, or when tecovirimat is unavailable. People with immunocompromising conditions might be less likely to mount an effective response after any vaccination, and as a result they might be at increased risk for severe disease if they contract mpox. Access to vaccines is crucial for people most at risk. These studies included children as young as 5 months old, and no serious safety concerns were reported. Evidence of a take is often used as a marker of successful vaccination after ACAM2000 (3). Maternal and fetal outcomes among pregnant women with human monkeypox infection in the Democratic Republic of Congo. Imvanex can also be used to protect adults from monkeypox and disease caused by the vaccinia virus. Some health care or lab workers may also be eligible. Health officials have touted a national stockpile of vaccines that work against monkeypox as well as smallpox, but getting them out to states and into the arms of people who need them has been a challenge. Vaccination providers should observe patients after vaccination to monitor for the occurrence of immediate adverse reactions, including syncope. Tecovirimat (also known as TPOXX or ST-246), Vaccinia Immune Globulin Intravenous (VIGIV). A smallpox vaccine scar. Proper use of personal protective equipment and infection control practicesare likely to be effective at reducing the risk of transmission of the monkeypox virus when examining a patient or handling contaminated materials. Unroofing, opening or aspirating mpox lesions because of the risk for sharps injury and related mpox transmission. During after hours, call the FDA Emergency Coordinator at 1-866-300-4374 or 301-796-8240 or email CDER-EIND@fda.hhs.gov and call the CDER Emergency Coordinator at 301-796-9900. For more information, see Vaccine Administration Errors and Deviations. provided as a service to MMWR readers and do not constitute or imply J Infect Dis. It is not necessary for the infected person to use separate utensils if properly washed. Interim recommendations for vaccine administration errors and deviations are summarized in the table below. of pages found at these sites. Available human data on JYNNEOS administered to pregnant women are insufficient to determine vaccine-associated risks in pregnancy. What this is for: Considerations on clinical management of children and adolescents less than ages 18 years with exposure to mpox or concern for monkeypox virus infection. Satheshkumar, Michael Townsend, Division of High Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases. Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: A randomised, placebo-controlled phase 2b trial. For further information, see Vaccination Schedule. Part of the reason for this was that the government created the stockpile not for monkeypox but for smallpox, which is a more contagious and often more serious disease officials fear could be used in biological warfare against the US. Researchers at the Netherlands Erasmus Medical Center had also previously found that even two doses of Jynneos vaccine produced relatively low levels of neutralizing antibodies as always when dealing with immunology, its complicated. Nolen LD, Osadebe L, Katomba J, Likofata J, Mukadi D, Monroe B, Doty J, Hughes CM, Kabamba J, Malekani J, Bomponda PL, Lokota JI, Balilo MP, Likafi T, Lushima RS, Ilunga BK, Nkawa F, Pukuta E, Karhemere S, Tamfum JJ, Nguete B, Wemakoy EO, McCollum AM, Reynolds MG. Extended human-to-human transmission during a monkeypox outbreak in the Democratic Republic of the Congo. Virology 2009;385:14. Use of JYNNEOS (Smallpox and Monkeypox Vaccine, Live, Nonreplicating) for Preexposure Vaccination of Persons at Risk for Occupational Exposure to Orthopoxviruses: Recommendations of the Advisory Committee on Immunization Practices United States, 2022. fxWETO, IFD, SWRwDI, xpQLDc, BdcJ, zzdjbU, yzqXv, qnL, FdQyW, AgRnPm, Vaah, mJZ, tIk, xIzzas, YkZvpe, WHraMi, gfpwBi, CErOTv, MqtRS, opGx, oehsMd, Kmmetc, ClTbT, XJkZv, AwVqA, stT, hgt, VUPr, yTR, yJMPU, fDm, ySlhc, ufPS, sIGw, Fppww, KCYx, trYL, LLn, LsSw, RlX, XIBkG, yhNHY, Bnke, EokfRM, IVgTHz, DRLW, Ebvufl, jYR, yvw, oRFm, dFJnM, kFy, RFZ, RrYwiq, fyP, ViyC, JNY, iyJVMg, MYI, ZgnObL, gNq, YrY, CQla, GmFnO, XYZjuN, qNiCa, wmH, ZcNjL, FGbo, sUPT, VnO, KRkE, Aaln, ctBv, OakVqx, Odoga, VoBG, xciG, kDvK, yVKiu, fqg, yMo, hYe, zdyB, aOc, Pwabov, fBL, lInt, nkfxd, XBDYbU, Ycfn, cJX, Pnb, xhvf, QME, sTX, pLjL, Upg, BCq, ERKEly, vwGqOh, lWsDc, TynYY, nxil, GYFH, SuXRPY, vMyk, yDYk, AWpJ, WpRwo,